BIOMAT Database Logo BIOMAT Database Logo

Synthesis and biological evaluation of novel bisbenzimidazoles as Escherichia coli topoisomerase IA inhibitors and potential antibacterial agents. 2014

Hemlata Nimesh, and Souvik Sur, and Devapriya Sinha, and Pooja Yadav, and Prachi Anand, and Priyanka Bajaj, and Jugsharan S Virdi, and Vibha Tandon
Department of Chemistry, University of Delhi , Delhi 110 007, India.

Novel bisbenzimidazole inhibitors of bacterial type IA topoisomerase are of interest for the development of new antibacterial agents that are impacted by target-mediated cross resistance with fluoroquinolones. The present study demonstrates the successful synthesis and evaluation of bisbenzimidazole analogues as Escherichia coli topoisomerase IA inhibitors. 5-(4-Propylpiperazin-1-yl)-2-[2'-(4-ethoxyphenyl)-5'-benzimidazolyl]benzimidazole (12b) showed significant relaxation inhibition activity against EcTopo 1A (IC50 = 2 ± 0.005 μM) and a tendency to chelate metal ion. Interestingly, these compounds did not show significant inhibition of E. coli DNA gyrase and hTop 1 even up to 100 μM. Compound 12b has shown lowest MIC against E. coli strains among 24 compounds evaluated. The binding affinity constant and binding free energy of 12b with EcTopo 1A was observed 6.8 × 10(6) M(-1) and -10.84 kcal mol(-1) from isothermal titration calorimetry (ITC), respectively. In vivo mouse systemic infection and neutropenic thigh model experimental results confirmed the therapeutic efficacy of 12b, suggesting further development of this class of compounds as antibacterial agents.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009503 Neutropenia A decrease in the number of NEUTROPHILS found in the blood. Neutropenias
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D004264 DNA Topoisomerases, Type I DNA TOPOISOMERASES that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. DNA Topoisomerases, Type I enzymes reduce the topological stress in the DNA structure by relaxing the superhelical turns and knotted rings in the DNA helix. DNA Nicking-Closing Protein,DNA Relaxing Enzyme,DNA Relaxing Protein,DNA Topoisomerase,DNA Topoisomerase I,DNA Topoisomerase III,DNA Topoisomerase III alpha,DNA Topoisomerase III beta,DNA Untwisting Enzyme,DNA Untwisting Protein,TOP3 Topoisomerase,TOP3alpha,TOPO IIIalpha,Topo III,Topoisomerase III,Topoisomerase III beta,Topoisomerase IIIalpha,Topoisomerase IIIbeta,DNA Nicking-Closing Proteins,DNA Relaxing Enzymes,DNA Type 1 Topoisomerase,DNA Untwisting Enzymes,DNA Untwisting Proteins,Topoisomerase I,Type I DNA Topoisomerase,III beta, Topoisomerase,III, DNA Topoisomerase,III, Topo,III, Topoisomerase,IIIalpha, TOPO,IIIalpha, Topoisomerase,IIIbeta, Topoisomerase,Topoisomerase III, DNA,Topoisomerase, TOP3,beta, Topoisomerase III
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D004927 Escherichia coli Infections Infections with bacteria of the species ESCHERICHIA COLI. E coli Infections,E. coli Infection,Infections, E coli,Infections, Escherichia coli,E coli Infection,E. coli Infections,Escherichia coli Infection,Infection, E coli,Infection, E. coli,Infection, Escherichia coli
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Hemlata Nimesh, and Souvik Sur, and Devapriya Sinha, and Pooja Yadav, and Prachi Anand, and Priyanka Bajaj, and Jugsharan S Virdi, and Vibha Tandon
Synthesis and Biological Evaluation of New Pyridothienopyrimidine Derivatives as Antibacterial Agents and Escherichia coli Topoisomerase II Inhibitors.
October 2020, Antibiotics (Basel, Switzerland),
Hemlata Nimesh, and Souvik Sur, and Devapriya Sinha, and Pooja Yadav, and Prachi Anand, and Priyanka Bajaj, and Jugsharan S Virdi, and Vibha Tandon
Synthesis and biological evaluation of novel benzoxazinyl-oxazolidinones as potential antibacterial agents.
July 2013, Bioorganic & medicinal chemistry letters,
Hemlata Nimesh, and Souvik Sur, and Devapriya Sinha, and Pooja Yadav, and Prachi Anand, and Priyanka Bajaj, and Jugsharan S Virdi, and Vibha Tandon
Synthesis and biological evaluation of pentacyclic triterpenoid derivatives as potential novel antibacterial agents.
April 2021, Bioorganic chemistry,
Hemlata Nimesh, and Souvik Sur, and Devapriya Sinha, and Pooja Yadav, and Prachi Anand, and Priyanka Bajaj, and Jugsharan S Virdi, and Vibha Tandon
Antitumor agents. 185. Synthesis and biological evaluation of tridemethylthiocolchicine analogues as novel topoisomerase II inhibitors.
May 1998, Journal of medicinal chemistry,
Hemlata Nimesh, and Souvik Sur, and Devapriya Sinha, and Pooja Yadav, and Prachi Anand, and Priyanka Bajaj, and Jugsharan S Virdi, and Vibha Tandon
Synthesis and biological evaluation of pyrazolopyrimidines as potential antibacterial agents.
December 2015, Bioorganic & medicinal chemistry letters,
Hemlata Nimesh, and Souvik Sur, and Devapriya Sinha, and Pooja Yadav, and Prachi Anand, and Priyanka Bajaj, and Jugsharan S Virdi, and Vibha Tandon
Synthesis and biological evaluation of novel indole-pyrazoline hybrid derivatives as potential topoisomerase 1 inhibitors.
February 2020, Bioorganic & medicinal chemistry letters,
Hemlata Nimesh, and Souvik Sur, and Devapriya Sinha, and Pooja Yadav, and Prachi Anand, and Priyanka Bajaj, and Jugsharan S Virdi, and Vibha Tandon
Synthesis and biological evaluations of novel benzimidazoles as potential antibacterial agents.
March 2004, Bioorganic & medicinal chemistry letters,
Hemlata Nimesh, and Souvik Sur, and Devapriya Sinha, and Pooja Yadav, and Prachi Anand, and Priyanka Bajaj, and Jugsharan S Virdi, and Vibha Tandon
Synthesis and biological evaluation of novel luteolin derivatives as antibacterial agents.
February 2009, European journal of medicinal chemistry,
Hemlata Nimesh, and Souvik Sur, and Devapriya Sinha, and Pooja Yadav, and Prachi Anand, and Priyanka Bajaj, and Jugsharan S Virdi, and Vibha Tandon
Synthesis and biological evaluation of novel 1,2,3,4-tetrahydro-β-carboline derivatives as potential antibacterial agents.
May 2024, Bioorganic & medicinal chemistry letters,
Hemlata Nimesh, and Souvik Sur, and Devapriya Sinha, and Pooja Yadav, and Prachi Anand, and Priyanka Bajaj, and Jugsharan S Virdi, and Vibha Tandon
Design, synthesis and biological evaluation of novel flavone Mannich base derivatives as potential antibacterial agents.
May 2019, Molecular diversity,
Copied contents to your clipboard!